Case of Ceftriaxone-Induced Immune Hemolytic Anemia in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit
Jaslyn Maurer, Samantha Ruddy, Monica Bapna, George Rodriguez & Sorana Segal-Maurer · International Journal of Medical and Pharmaceutical Case Reports · 2023
Background: Ceftriaxone is a commonly used antimicrobial agent for the treatment of various infections. It is frequently administered once daily and is an attractive option for use in both in- and out-patient settings. Ceftriaxone-induced immune hemolytic anemia, while rare, can...
Open access
Research Article
10.9734/ijmpcr/2023/v16i4357